|
市場調査レポート
商品コード
1512639
中国のゲノムベース医薬品市場Genome-Based Drug Markets in China |
||||||
適宜更新あり
|
|||||||
| 中国のゲノムベース医薬品市場 |
|
出版日: 2024年07月08日
発行: Asia Market Information & Development Co.
ページ情報: 英文 240 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
当レポートでは、中国のゲノムベース医薬品市場の最新情勢と将来展望について分析し、全体的なビジネス環境や、業界全体の市場規模の過去のデータ (2013年/2018年/2023年)および2028年から2033年までの長期予測、製品別の詳細動向、主要企業のプロファイルと業績動向などの情報を取りまとめてお届けいたします。
目次
第1章 イントロダクション
- 調査範囲・手法
- エグゼクティブサマリー
第2章 ビジネス環境
- 経済展望
- 主要経済指標
- 工業生産
- 人口・労働力
- 直接投資
- 対外貿易
- 金融・税務規制
- 銀行システムと規制
- 外国為替
- 税制と関税
第3章 ゲノムベース医薬品産業の評価
- ゲノムベース医薬品産業の構造
- 市場規模
- 市場成長の促進要因
- 主要メーカーの生産拠点・生産量
- 主要メーカーの市場シェア
- 人件費
- 潜在的な参入企業
- 主な海外投資
- 技術開発
第4章 ゲノムベース医薬品の販売量と予測
- 概要
- ゲノムベース医薬品の販売量と予測（単位：元）
- サイトカイン薬
- ペプチドホルモン薬
- 血栓溶解剤
- 酵素薬
- 可溶性受容体
- 接着分子
- 核酸医薬品
- その他のゲノムベース医薬品
- ゲノムベース医薬品の輸出・輸入
- 価格動向
第5章 ゲノム医薬品市場の展望
- ゲノムベース医薬品市場の展望：概要
- 政府の規制
- 医療保険業界の概要
- 消費者支出動向
- 人口動向
- 医療業界の動向
- 病院数と病床数
- ゲノムベース医薬品の売上高：地域別
- 東部
- 北部
- 中部
- 南部
- 西部
第6章 マーケティング戦略
- 中国市場の概要
- 中国の流通システム
- ゲノムベース医薬品の流通経路
- 交通・貨物輸送インフラ
- 通信
- 中国市場への参入経路
- ライセンス契約
- フランチャイズ
- 電子商取引 (eコマース)
- 商社と現地代理店
- 駐在員事務所と中国子会社
- 完全外資系企業
第7章 ゲノムベース医薬品メーカーの一覧
- ゲノムベース医薬品メーカーのプロファイル
- 流通業者・商社
- 研究機関・業界団体
LIST OF TABLES
I. INTRODUCTION
- Economic Outlook Summary
- Genome-Based Drug Supply and Demand Summary
II. BUSINESS ENVIRONMENT
- Key Economic Indicators
- Industrial Output
- Population and Labor Force Trends
- Foreign Investment and Loans
- Foreign Trade
- Key Commodity Exports from China
- China's Exports to its Leading Trade Partners
- Key Commodity Imports into China
- China's Imports from Its Leading Trade Partners
III. GENOME-BASED DRUG INDUSTRY ASSESSMENTS
- Major Producer Facility Locations
- Major Genome-Based Drug Producer Output
- Market Share of Key Producers
- Major Foreign Investments
IV. GENOME-BASED DRUG SALES VOLUMES AND FORECASTS
- Overview
- Genome-Based Drug Sales Volumes and forecasts (Yuan)
- Cytokines Drug
- Peptide Hormones Drug
- Thrombolytic Agents
- Enzyme Drug
- Soluble Recepter
- Adhesion Molecule
- Nucleic Acid Drug
- Other Genome-Based Drug
- Genome-Based Drug Imports and Exports
- Pricing Trends
V. GENOME-BASED DRUG Y MARKET OUTLOOKS
- Total Genome-Based Drug Consumption by Market
- Consumer Spending Trends
- Demographic Trends
- Health Care Industry Trends
- Hospitals and Hospital Beds
- Genome-Based Drug Sales by Region
- Northeast
- North
- Southeast
- Central
- Southwest
- Northwest
LIST OF CHARTS
I. INTRODUCTION
- Economic Outlook Summary
- Genome-Based Drug Supply and Demand Summary
II. BUSINESS ENVIRONMENT
- Key Economic Indicators
- Industrial Output
- Population and Labor Force Trends
- Foreign Investment and Loans
- Foreign Trade
- Key Commodity Exports from China
- China's Exports to its Leading Trade Partners
- Key Commodity Imports into China
- China's Imports from Its Leading Trade Partners
III. GENOME-BASED DRUG INDUSTRY ASSESSMENTS
- Major Producer Facility Locations
- Major Genome-Based Drug Producer Output
- Market Share of Key Producers
- Major Foreign Investments
IV. GENOME-BASED DRUG SALES VOLUMES AND FORECASTS
- Overview
- Genome-Based Drug Sales Volumes and forecasts (Yuan)
- Cytokines Drug
- Peptide Hormones Drug
- Thrombolytic Agents
- Enzyme Drug
- Soluble Recepter
- Adhesion Molecule
- Nucleic Acid Drug
- Other Genome-Based Drug
- Genome-Based Drug Imports and Exports
- Pricing Trends
V. GENOME-BASED DRUG Y MARKET OUTLOOKS
- Total Genome-Based Drug Consumption by Market
- Consumer Spending Trends
- Demographic Trends
- Health Care Industry Trends
- Hospitals and Hospital Beds
- Genome-Based Drug Sales by Region
- Northeast
- North
- Southeast
- Central
- Southwest
- Northwest
China's demand for Genome-Based Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2013, 2018 and 2023) and long-term forecasts through 2028 and 2033 are presented. Major producers in China are profiled.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.
Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.
TABLE OF CONTENTS
I. INTRODUCTION
- Report Scope and Methodology
- Executive Summary
II. BUSINESS ENVIRONMENT
- Economic Outlook
- Key Economic Indicators
- Industrial Output
- Population and Labor
- Foreign Investment
- Foreign Trade
- Financial and Tax Regulations
- Banking System and Regulations
- Foreign Exchange
- Taxes, Tariff and Custom Duties
III. GENOME-BASED DRUG INDUSTRY ASSESSMENTS
- Genome-Based Drug Industry Structure
- Market Size
- Market Growth Drivers
- Major Producer Facility Locations and Output
- Market Share of Key Producers
- Labor Costs
- Potential Entrants
- Major Foreign Investments
- Technology Development
IV. GENOME-BASED DRUG SALES VOLUMES AND FORECASTS
- Overview
- Genome-Based Drug Sales Volumes and Forecasts (Yuan)
- Cytokines Drug
- Peptide Hormones Drug
- Thrombolytic Agents
- Enzyme Drug
- Soluble Recepter
- Adhesion Molecule
- Nucleic Acid Drug
- Other Genome-Based Drug
- Genome-Based Drug Imports and Exports
- Pricing Trends
V. GENOME-BASED DRUG MARKET OUTLOOKS
- Genome-Based Drug Markets Outlook Overview
- Government Regulations
- Health Care Insurance Industry Overview
- Consumer Spending Trends
- Demographic Trends
- Health Care Industry Trends
- Hospitals and Hospital Beds
- Genome-Based Drug Sales by Region
- East
- North
- Central
- South
- West
VI. MARKETING STRATEGIES
- Distribution System in China
- China's Distribution System
- Genome-Based Drug Distribution Channels
- Transportation and Freight Infrastructure
- Communications
- China's Market Entry
- Licensing
- Franchising
- E-commerce
- Trading Companies and Local Agents
- Representative Offices and Chinese Subsidiaries
- Wholly Foreign Owned Enterprises
VII. GENOME-BASED DRUG PRODUCER DIRECTORY
- Genome-Based Drug Producer Profiles
- Distributors and Trading Companies
- Research Institutions and Associations